CIK 0001411685 · Non-accelerated filer<br>Smaller reporting company
Vistagen Therapeutics, Inc.
Sign in to watch- Ticker
- VTGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 205093315
- Phone
- 650-577-3600
- Business address
- 343 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Excaliber Enterprises, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 51 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-12-30 | Cunningham Ann Michelle Director | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2020-12-30 | Singh Shawn CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2020-12-30 | DOTSON JERROLD DUANE VP, CFO AND SECRETARY | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2020-12-30 | Smith Mark Alan CHIEF MEDICAL OFFICER | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2020-12-30 | SAXE JON S Director | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2020-12-30 | Underdown Brian J. Director | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2020-12-30 | MCPARTLAND MARK A. VP CORPORATE DEVELOPMENT | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2020-12-30 | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2020-12-30 | GIN JERRY B Director | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2020-08-21 | SAXE JON S Director | Purchase | +30,000 | $0.69 | $21K | 50,000 |
| 2020-06-30 | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | Grant or award | +5,000 | $0.45 | $2K | 67,724 |
| 2020-06-30 | Smith Mark Alan CHIEF MEDICAL OFFICER | Grant or award | +5,000 | $0.45 | $2K | 5,000 |
| 2020-06-30 | DOTSON JERROLD DUANE VP, CFO AND SECRETARY | Grant or award | +5,000 | $0.45 | $2K | 5,000 |
| 2020-06-30 | Singh Shawn CHIEF EXECUTIVE OFFICER | Grant or award | +5,000 | $0.45 | $2K | 30,375 |
| 2020-04-23 | MCPARTLAND MARK A. VP CORPORATE DEVELOPMENT | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2020-04-23 | DOTSON JERROLD DUANE VP, CFO AND SECRETARY | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2020-04-23 | Smith Mark Alan CHIEF MEDICAL OFFICER | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2020-04-23 | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2020-04-23 | Singh Shawn CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2020-04-23 | Cunningham Ann Michelle Director | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 |
Page 7 of 17 · 323 trades